Paracetamol disposition in renal allograft recipients

European Journal of Clinical Pharmacology

Volumn 57, Issue 12, 2002, Pages 853-856

  Martin, U ^a   Temple, R ^b   Venkat Raman, G ^c   Prescott, L ^d  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Paracetamol; Renal allograft

Indexed keywords

CREATININE; DRUG RESIDUE; GLUCURONIDE; PARACETAMOL; SULFATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONJUGATE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; CREATININE BLOOD LEVEL; DIET RESTRICTION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SCREENING; DRUG URINE LEVEL; FEMALE; HUMAN; KIDNEY ALLOGRAFT; KIDNEY CLEARANCE; KIDNEY FUNCTION; MALE; PRIORITY JOURNAL; TIME;

ACETAMINOPHEN; ADULT; ANALGESICS, NON-NARCOTIC; FEMALE; GLUCURONIDES; HALF-LIFE; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 0035722154     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-001-0409-2     Document Type: Article

References (16)

1. Clinical pharmacokinetics in organ transplant patients
2. Pharmacokinetics and nephrotoxicity of cyclosporine in renal transplant recipients
3. Prednisone and prednisolone bioavailability in renal transplant patients
4. Day-to-day variability in azathioprine pharmacokinetics in renal transplant recipients
5. Paracetamol disposition and metabolite kinetics in patients with chronic renal failure
6. The role of sulphate conjugation in the metabolism and disposition of oral and intravenous paracetamol in man
7. Inhibition of gastric emptying and drug absorption by narcotic analgesics
8. Some factors affecting the absorption of paracetamol
9. Reduction of absorption of paracetamol by activated charcoal and cholestyramine: A possible therapeutic measure
10. The dependence of paracetamol absorption on the rate of gastric emptying
11. Data point weighting in pharacokinetic analysis: Intravenous paracetamol in man
12. Drug metabolites in renal failure: Pharmacokinetic and clinical implications
13. Clinical pharmacokinetics of paracetamol
14. Biliary excretion of acetaminophen in ureter-ligated rats
15. The disposition of paracetamol and the accumulation of its glucuronide and sulphate conjugates during multiple dosing in patients with chronic renal failure
16. The disposition of paracetamol and its conjugates during multiple dosing in patient with end-stage renal failure maintained on haemodialysis